Angiotensin II regulates extraneuronal dopamine uptake in the kidney

Nephron - Physiology

Volumn 104, Issue 4, 2006, Pages

  Choi, Marcelo R ^a   Correa, Alicia H ^a   Del Valle Turco, Vanesa ^a   Garcia, Fernando Aprile ^a   Fernández, Belisario E ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

Angiotensin II; AT1 receptor; AT2 receptor; Dopamine; Kidney

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; DOPAMINE; DOPAMINE RECEPTOR; LOSARTAN; SODIUM ION; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINE METABOLISM; DOPAMINE UPTAKE; IN VITRO STUDY; ISOTOPE LABELING; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE CELL; MALE; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SODIUM ABSORPTION; SODIUM TRANSPORT; WATER TRANSPORT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROCORTISONE; IMIDAZOLES; KIDNEY; KIDNEY TUBULES, PROXIMAL; LOSARTAN; MALE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SODIUM; TEMPERATURE; TIME FACTORS;

EID: 33845332985     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095856     Document Type: Article

References (40)

1. Aperia A: Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000;62:621-647.
2. Zhuo J, Harris PJ, Skinner SL: Modulation of proximal tubular reabsorption by angiotensin II. Clin Exp Pharmacol Physiol 1986;13:277-281.
3. Ursula C, Brewster MD, Mark A, Perazella MD: The renin-angiotensin- aldosterone system in the kidney: effects on kidney disease. Am J Med 2004;116:263-272.
4. Zhuo J, Alcorn D, Allen AM, Mendelsohn FA: High resolution localization of angiotensin II receptors in rat renal medulla. Kidney Int 1992;42:1372-1380.
5. Lokhandwala MF, Barrett RJ: Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications. J Auton Pharmacol 1982;4:189-215.
6. Lockhandwala MF, Vyas SJ, Hedge SS: Renal dopamine and dopamine receptors in the regulation of sodium excretion. J Auton Pharmacol 1990;10(suppl 1):s57-s65.
7. Vatta MS, Papouchado ML, Bianciotti LG, Fernández BE: Atrial natriuretic factor inhibits noradrenaline release in presence of angiotensin II and III in the rat hypothalamus. Comp Biochem Physiol C 1993;106:545-548.
8. Fernández BE, Domínguez AE, Vatta MS, Méndez MA, Bianciotti LG, Martínez Seeber A: Atrial natriuretic peptide and angiotensin II interaction on noradrenaline uptake in the central nervous system. Arch Int Pharmacodyn Ther 1990;307:11-17.
9. Fernández BE, Correa AH, Choi MR: Atrial natriuretic factor stimulates renal dopamine uptake mediated by natriuretic peptide-type A receptor. Regul Pept 2005;124:137-144.
10. Fernández BE, Domínguez AE, Vidal NA, Taquini AC Jr: Renal denervation and catecholamines of the central nervous system. Neuroendocrinology 1974;15:338-345.
11. Domínguez AE, Fernández BE, Vidal NA, Martínez- Seeber A: Angiotensin II-norepinephrine relationship in the central nervous system. Arch Int Physiol Biochim 1982;90:269-275.
12. Vatta MS, Bianciotti LG, Locatelli AS, Papouchado ML, Fernandez BE: Monophasic and biphasic effects of angiotensin II and III on norepinephrine uptake and release in rat adrenal medulla. Can J Physiol Pharmacol 1992;70:821-825.
13. Papouchado ML, Vatta MS, Escalada A, Bianciotti LG, Fernández BE: Angiotensin III modulates noradrenaline uptake and release in the rat hypothalamus. J Auton Pharmacol 1995;15:1-8.
14. Gorgiev V, Gyorgy L, Yonkov D, Getova D, Markovska V, Petkova B: Dopaminergic influence on the effects of angiotensin II in behavioral reactions. Physiol Bohomoslov 1985;34(suppl):45-48.
15. Gorgiev V, Gyorgy L, Getova D, Markovska V: Some central effects of angiotensin II. Interactions with dopaminergic transmission. Acta Physiol Pharmacol Bulg 1985;11:19-26.
16. Yonkov DI, Georgiev VP, Opitz MJ: Participation of angiotensin II in learning and memory. II. Interactions of angiotensin II with dopaminergic drugs. Methods Find Exp Clin Pharmacol 1986;8:203-206.
17. Braszko J, Wisniewski K: Effect of angiotensin on the central action of dopamine. Pol J Pharmacol Pharm 1976;28:667-672.
18. Hirano T, Nagai K, Nakagawa H: Uptake of [3H]dopamine in isolated chromaffin cells of the mouse: modulation by intra- and extra-adrenal peptides and other secretagogues. J Auton Nerv System 1998;69:198-204.
19. Dinh DT, Frauman AG, Johnston CI, Fabiani ME: Angiotensin receptors: distribution, signaling and function. Clin Sci (Lond) 2001;100:481-492.
20. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V: Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 1998;273:32776-32786.
21. Gründemann D, Liebich G, Kiefer N, Köster S, Schömig E: Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 1999;56:1-10.
22. Eisenhofer G: The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 2001;91:35-62.
23. Gründemann D, Köster S, Kiefer N, Breidert T, Engelhardt M, Spitzenberger F, et al: Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J Biol Chem 1998;273:30915-30920.
24. Breidert T, Spitzenberger F, Gründemann D, Schömig E: Catecholamine transport by the organic cation transporter type 1 (OCT1). Br J Pharmacol 1998;125:218-224.
25. Mühlbauer B, Osswald H: Feeding but not salt loading is the dominant factor controlling urinary dopamine excretion in conscious rats. Naunyn Schmiedebergs Arch Pharmacol 1992;346:469-471.
26. Carranza A, Nowicki S, Barontini M, Armando I: L-Dopa uptake and dopamine production in proximal tubular cells are regulated by β2-adrenergic receptors. Am J Physiol Renal Physiol 2000;279:F77-F83.
27. Hagege J, Richet G: Proximal tubule dopamine histofluorescence in renal slices incubated with L-Dopa. Kidney Int 1985;27:3-8.
28. Carey RM: Renal dopamine system. Paracrine regulator of sodium homeostasis and blood pressure. Hypertension 2001;38:297-302.
29. Aperia A, Fryckstedt J, Holtbäck U, Belusa R, Cheng X-J, Eklöf A-C, et al: Cellular mechanisms for bi-directional regulation of tubular sodium reabsorption. Kidney Int 1996;49:1743-1747.
30. Missale C, Russel Nash S, Robinson SW, Jaber M, Caron MG: Dopamine receptors: from structure to function. Physiol Rev 1998;78:189-225.
31. Holtbäck U, Kruse MS, Brismar H, Aperia A: Intrarenal dopamine coordinates the effect of antinatriuretic and natriuretic factors. Acta Physiol Scand 2000;168:215-218.
32. + exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 1990;259:F297-F303.
33. Ball SG, Lee MR: Increased urinary dopamine in salt loaded rats. Clin Sci Mol Med 1977;52:20-21.
34. Pendleton RG, Sherman SS: Studies concerning dopamine diuresis in the rat. Arch Int Pharmacodyn Ther 1976;222:94-102.
35. Chen CJ, Apparsundaram S, Lokhandwala MF: Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J Pharmacol Exp Ther 1991;256:486-491.
36. Hughes JM, Beck TR, Rose CE Jr, Carey RM: The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man. J Clin Endocrinol Metab 1988;66:518-525.
37. Rodríguez-Campos M, Kadarian C, Rodano V, Bianciotti L, Fernández B, Vatta M: AT1 receptor and phospholipase C are involved in angiotensin III modulation of hypothalamic noradrenergic transmission. Cell Mol Neurobiol 2000;20:747-762.
38. Holtbäck U, Brismar H, Di Bona GF, Fu M, Greengard P, Aperia A: Receptor recruitment: a mechanism of interaction between G-protein coupled receptors. Proc Natl Acad Sci USA 1999;96:7271-7275.
39. Féraille E, Doucet A: Sodium-potassium-adenosinetriphosphatase- dependent sodium transport in the kidney: hormonal control. Physiol Rev 2001;81:345-418.
40. +-ATPase: a final common pathway for regulation of natriuresis. FASEB J 1994;8:436-439.